1. Home
  2. NSPR vs FMN Comparison

NSPR vs FMN Comparison

Compare NSPR & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • FMN
  • Stock Information
  • Founded
  • NSPR 2005
  • FMN 2002
  • Country
  • NSPR United States
  • FMN United States
  • Employees
  • NSPR N/A
  • FMN N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • FMN Investment Managers
  • Sector
  • NSPR Health Care
  • FMN Finance
  • Exchange
  • NSPR Nasdaq
  • FMN Nasdaq
  • Market Cap
  • NSPR 99.7M
  • FMN 85.6M
  • IPO Year
  • NSPR N/A
  • FMN N/A
  • Fundamental
  • Price
  • NSPR $1.81
  • FMN $11.09
  • Analyst Decision
  • NSPR Strong Buy
  • FMN
  • Analyst Count
  • NSPR 2
  • FMN 0
  • Target Price
  • NSPR $4.50
  • FMN N/A
  • AVG Volume (30 Days)
  • NSPR 119.5K
  • FMN 22.8K
  • Earning Date
  • NSPR 11-04-2025
  • FMN 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • FMN 3.86%
  • EPS Growth
  • NSPR N/A
  • FMN N/A
  • EPS
  • NSPR N/A
  • FMN N/A
  • Revenue
  • NSPR $7,779,000.00
  • FMN N/A
  • Revenue This Year
  • NSPR $7.48
  • FMN N/A
  • Revenue Next Year
  • NSPR $104.39
  • FMN N/A
  • P/E Ratio
  • NSPR N/A
  • FMN N/A
  • Revenue Growth
  • NSPR 14.04
  • FMN N/A
  • 52 Week Low
  • NSPR $1.77
  • FMN $9.09
  • 52 Week High
  • NSPR $3.80
  • FMN $11.31
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 22.72
  • FMN 54.23
  • Support Level
  • NSPR $2.05
  • FMN $11.02
  • Resistance Level
  • NSPR $2.40
  • FMN $11.22
  • Average True Range (ATR)
  • NSPR 0.15
  • FMN 0.09
  • MACD
  • NSPR -0.03
  • FMN -0.01
  • Stochastic Oscillator
  • NSPR 29.05
  • FMN 35.00

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About FMN Federated Hermes Premier Municipal Income Fund

Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.

Share on Social Networks: